Probiotics in curing allergic and inflammatory conditions – Research progress and futuristic vision

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 10, Issue 2, 2016, Pages 105-118

  Dhama, Kuldeep ^a   Latheef, Shyma K ^a   Munjal, Ashok K ^b   Khandia, Rekha ^b   Samad, Hari A ^a   Iqbal, Hafiz M N ^c   Joshi, Sunil K ^d  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b BARKATULLAH UNIVERSITY   (India)

^c SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^d OLD DOMINION UNIVERSITY   (United States)

Author keywords

Allergy; Beneficial microbes; Immune response; Immunomodulation; Inflammation; Modes of action; Probiotics; Treatment

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; ASTHMA; BIFIDOBACTERIUM; CELL INFILTRATION; DIABETES MELLITUS; DIARRHEA; DOWN REGULATION; ECZEMA; ESCHERICHIA COLI; HUMAN; ILEITIS; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; LACTOBACILLUS; LACTOSE INTOLERANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS; URINARY TRACT INFECTION; VAGINITIS; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; PATENT;

ANIMALS; BIFIDOBACTERIUM; HUMANS; HYPERSENSITIVITY; INFLAMMATION; LACTOBACILLUS; PATENTS AS TOPIC; PROBIOTICS;

EID: 85017541338     PISSN: 1872213X     EISSN: 22122710     Source Type: Journal    
DOI: 10.2174/1872213X10666161226162229     Document Type: Review

References (189)

1. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbioticsapproaching a definition. Am J Clin Nutr 2001; 73(Suppl): 361S-4S.
2. Dhama K, Mahendran M, Tomar S, Chauhan RS. Beneficial effects of probiotics and prebiotics in livestock and poultry: The current perspectives. Intaas Polivet 2008; 9(1): 1-13.
3. Dhama K, Verma V, Sawant PM, Tiwari R, Vaid RK, Chauhan RS. Applications of probiotics in poultry: Enhancing immunity and beneficial effects on production performances and health-A review. J Immunol Immunopathol 2011; 13(1): 1-19.
4. Gill H, Prasad J. Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 2008; 606: 423-54.
5. Sanders ME. Probiotics: Definition, sources, selection, and uses. Clin Infec Dis 2008; 46: S58-61.
6. Sanders ME. Probiotics in 2015: Their scope and use. J Clin Gastroenterol 2015; 49 (Suppl 1): S2-6.
7. Musa HH, Wu SL, Zhu CH, Seri HI, Zhu GQ. The potential benefits of probiotics in animal production and health. J Anim Vet Adv 2009; 8: 313-21.
8. Singh K, Kallali B, Kumar A, Thaker V. Probiotics: A review. Asian Pac J Trop Biomed 2011; 1(2): S287-S90.
9. Tiwari G, Tiwari R, Pandey S, Pandey P. Promising future of probiotics for human health: Current scenario. Chron Young Sci 2012; 3(1): 17.
10. Smith JM. A review of avian probiotics. J Avian Med Surg 2014; 28(2): 87-94.
11. Zorriehzahra MJ, Delshad ST, Adel M, Tiwari R, Karthik K, Dhama K, et al. Probiotics as beneficial microbes in aquaculture: An update on their multiple modes of action: A review. Vet Quart 2016; 36(4): 228-41.
12. Koop-Hoolihan L.: Prophylactic and therapeutic uses of probiotics: A review. J Anim Diet Assoc 2001; 101: 229-38, 241.
13. Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: A modern perspective on a traditional therapy. Clin Infect Dis 2001; 32: 1567-76.
14. Ouwehand AC. Antiallergic effects of probiotics. J Nutr 2007; 137(3): 794S-7S.
15. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol 2009; 44: 26-46.
16. Callaway TR, Edrington TS, Anderson RC, Harvey RB, Genovese KJ, Kennedy CN, et al. Probiotics, prebiotics and competitive exclusion for prophylaxis against bacterial disease. Anim Health Res Rev 2008; 9(2): 217-25.
17. Saini R, Saini S, Sugandha. Probiotics: The health boosters. J Cutan Aesthet Surg 2009; 2(2): 112.
18. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 2010; 29(6): 701-25.
19. Savilahti E. Probiotics in the treatment and prevention of allergies in children. Biosci Microflora 2011; 30(4): 119-28.
20. Daniluk U. Probiotics, the new approach for cancer prevention and/or potentialization of anti-cancer treatment? J Clin Exp Oncol 2012; 1: 2.
21. Trafalska E, Grzybowska K. Probiotics-an alternative for antibiotics? Wiad Lek 2004; 57(9-10): 491-98.
22. Dhama K, Chakraborty S, Tiwari R, Verma AK, Saminathan M. Amarpal, et al. A concept paper on novel technologies boosting production and safeguarding health of humans and animals. Res Opin Anim Vet Sci 2014; 4(7): 353-70.
23. Toh ZQ, Anzela A, Tang ML, Licciardi PV. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol 2012; 3: 1-14.
24. Cabana MD, McKean M, Wong AR, Chao C, Caughey AB. Examining the hygiene hypothesis: The trial of infant probiotic supplementation. Paediatr Perinat Epidemiol 2007; 21 (Suppl 3): 23-8.
25. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000; 30: 61-7.
26. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-34.
27. Forsberg A, West CE, Prescott S, Jenmalm MC. Pre-and probiotics for allergy prevention: Time to revisit recommendations? Clin Exp Allergy 2016; 46 (12): 1506-21.
28. West CE. Probiotics for allergy prevention. Benef Microbes 2016; 7(2): 171-79.
29. Dhama K, Chakraborty S Mahima, Wani MY, Verma AK, Deb R, et al. Novel and emerging therapies safeguarding health of humans and their companion animals: A review. Pak J Biol Sci 2013; 16(3): 101-11.
30. Dhama K, Saminathan M, Jacob SS, Singh M, Karthik K, Amarpal, et al. Effect of immunomodulation and immunomodulatory agents on health with some bioactive principles, modes of action and potent biomedical applications. Int J Pharmacol 2015; 11(4): 253-90.
31. Mahima Rahal A, Deb R, Latheef SK, Samad HA, Tiwari R, et al. Immunomodulatory and therapeutic potentials of herbal, traditional/ indigenous and ethnoveterinary medicines. Pak J Biol Sci 2012; 15(16): 754-74.
32. Tiwari R, Chakraborty S, Dhama K, Wani MY, Kumar A, Kapoor S. Wonder world of phages: Potential biocontrol agents safeguarding biosphere and health of animals and humans-current scenario and perspectives. Pak J Biol Sci 2014; 17(3): 316-28.
33. Tiwari R, Chakraborty S, Dhama K, Rajagunalan S, Singh SV. Antibiotic resistance-an emerging health problem: Causes, worries, challenges and solutions-A review. Int J Curr Res 2013; 5: 1880-92.
34. Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, et al. Oxidative stress, prooxidaand antioxidants: The interplay. BioMed Res Intl 2014; Article ID 761264, 19 pages.
35. Oyetayo VO, Oyetayo FL. Potential of probiotics as biotherapeutic agents targeting the innate immune system. Afr J Biotechnol 2005; 4(2): 123-27.
36. Sharma S, Arora M, Baldi A. Probiotics in India: Current status and future prospects. Pharm Aspire 2013; 1: 4-68.
37. Nagpal R, Kumar A, Kumar M, Behare PV, Jain S, Yadav H. Probiotics, their health benefits and applications for developing healthier foods: A review. FEMS microbiol Lett 2 012; 334(1): 1-15.
38. Khurshid M, Aslam B, Nisar MA, Akbar R, Rahman H, Khan AA, et al. Bacterial munch for infants: Potential pediatric therapeutic interventions of probiotics. Future Microbiol 2015; 10: 1881-95.
39. Sullivan A, Nord CE. The place of probiotics in human intestinal infections. Intl J Antimicrob Agents 2002; 20: 313-19.
40. Senok AC, Ismaeel AY, Botta GA. Probiotics: Facts and myths. Clin Microbiol Infec 2005; 11(12): 958-66.
41. Kesarcodi-Watson A, Kaspar H, Lategan MJ, Gibson L. Probiotics in aquaculture: The need, principles and mechanisms of action and screening processes. Aquaculture 2008; 274: 1-14.
42. Michail S. The role of probiotics in allergic diseases. Allergy Asthma Clin Immunol 2009; 5: 5.
43. Bottazzi V. Food and feed production with microorganisms. Biotechnol 1983; 5: 315-63
44. Metchnikoff E. The prolongation of life. Optimistic studies. London: Butterworth-Heinemann, 1907.
45. Tannock GW. Probiotic properties of lactic-acid bacteria: Plenty of scope for fundamental R & D. Trends in Biotechnol 1997; 15(7): 270-74.
46. Tissier H. Taxonomy and ecology of Bifidobacteria. Bifidobac Microflora 1984; 3: 11-28.
47. Rettger LF, Levy MN, Weinstein L, Weiss JE. Lactobacillus acidophilus and its therapeutic application. London: Yale University Press, 1935.
48. Kopeloff N. Lactobacillus acidophilus. Baltimore: Williams & Wilkins, 1926.
49. Bohnhoff N, Drake BL, Muller CP. Effect of streptomycin on susceptibility of the intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med 1954; 86: 132-7.
50. Freter R. The fatal enteric cholera infection in the guinea pig achieved by inhibition of normal enteric flora. J Infect Dis 1955; 97: 57-64.
51. Freter R. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs. J Exp Med 1956; 104: 411-8.
52. Collins FM, Carter PB. Growth of Salmonellae in orally infected germ free mice. Infect Immun 1978; 21: 41-7.
53. Alexandre Y, Le Blay G, Boisramé-Gastrin S, Le Gall F, Héry-Arnaud G, Gouriou S, et al. Probiotics: A new way to fight bacterial pulmonary infections? Med Maladies Infect 2014; 44(1): 9-17.
54. Food and Agriculture Organization, World Health Organization (FAO/WHO). Report of Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO Report no. 10-1-2001.WHOINT; Córdoba, Argentina.
55. Ozdemir O. Gut flora development in infancy and its effect on immune system. Çocuk Enf Derg (J Pediatr Inf) 2009; 3: 202-3.
56. Ozdemir O. Any benefits of probiotics in allergic disorders? Allergy Asthma Proc 2010; 31: 1-9.
57. Lee J, Yang W, Hostetler A, Schultz N, Suckow MA, Stewart KL, et al. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice. BMC Microbiol 2016; 16: 69.
58. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
59. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, et al. Dietary prebiotics: Current status and new definition. Food Sci Technol Bull: Funct Foods 2010; 7: 1-19.
60. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: Metabolic and health benefits. Br J Nutr 2010; 104: S1-S63.
61. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GM, Neyrinck AM, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60(11): 2775-86.
62. Everard A, Lazarevic V, Gaïa N, Johansson M, Ståhlman M, Backhed F, et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J 2014; 8(10): 2116-30.
63. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PGB, Neyrinck AM, et al. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013; 62(8): 1112-21.
64. Foye OT, Huang IF, Chiou CC, Walker WA, Shi HN. Early administration of probiotic Lactobacillus acidophilus and/ or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signalling. FEMS Immunol Med Microbiol 2012; 65(3): 467-80.
65. Tzortzis, G., Vulevic, J., Attanasio, F. Use of prebiotic galactooligosaccharides in the treatment of intestinal inflammation. CA2724766 (2010).
66. Guigoz, Y., Rochat, F., Schiffrin, E. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters. EP01243273 (2002).
67. Nikl, L.H., Allbright, L.J. Composition and method to enhance the efficacy of a fish vaccine and to stimulate the immune system of fish. US5189028 (1993).
68. Hibberd, P., Gorbach, S., Snydman, D., Goldin, B. Compositions and methods for enhancing the efficacy of vaccines. WO2006124630 (2006).
69. Bonini, S., Lambiase, A., Bonini, S. Use of probiotics in the prevention and treatment of allergic conjunctivitis. WO2007125566 (2007).
70. Tang, M.L. A method of inducing tolerance to an allergen. EP2244734 (2016).
71. Ouwehand, A., Rautonen, N., Salminen, S.J., Isolauri, E. Probiotics for use in reducing eosinophilia and respiratory allergies. US8936928 (2015).
72. van Tol, E.A.F., Russell, W.M., Herz, U., Renz, H., Garn, H., Braaksma, M., Van Der, W.M.J., Overkamp, K.M. Probiotic material. US20110217402 (2011).
73. Knorr, R., Cavadini, C., Benyacoub, J., Satyaraj, E. Probiotic enterococci for improved immunity. CA2624964 (2015).
74. Reinhart, G., Traudt, M. Probiotic/antioxidant blend. WO2013137899 (2013).
75. Zink, R., Reniero, R., Rochat, F., Cavadini, C., Weid, T., Schiffrin, E., Benyacoub, J., Rousseau, V., Perez, P. Novel probiotic strains for pets. US20050106133 (2005).
76. Zink, R., Reniero, R., Rochat, F., Cavadini, C., Weid, T., Schiffrin, E., Benyacoub, J., Rousseau, V., Perez, P., Knorr, R. Probiotic lactobacillus strains for pets. US7381406 (2008).
77. Zink, R., Reniero, R., Rochat, F., Cavadini, C., Weid, T., Schiffrin, E., Benyacoub, J., Rousseau, V., Perez, P., Knorr, R. Probiotic strains for pets. US8771675 (2008).
78. McMahon, R.J., Russell, W.M., Herz, U., Neu, J. Method for treating or preventing systemic inflammation. CA2679374 (2008).
79. Herz, U., McMahon, R.J., Russell, W.M., Neu, J. Product containing inactivated probiotic for children or infants. CA2676956 (2015).
80. Berry, D., Kaplan, J. Probiotic compositions containing clostridials for inhibiting inflammation. WO2016086206 (2016).
81. Rahman, S., Berry, D., Afeyan, N.B., Kaplan, J. Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome. WO2016086205 (2016).
82. McMahon, R.J., Russell, W.M., Herz, U., Neu, J. Method for the utilization of and product containing inactivated probiotic. US20080206212 (2008).
83. Rahman, S., Berry, D., Afeyan, N.B., Kaplan, J., Gordon, N. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease. WO2016086208 (2016).
84. Kunze, W., Bienenstock, J., Forsythe, P. Probiotics to prevent inflammation. WO2008064489 (2008).
85. Benyacoub, J., Corthesy, B., Blum-Sperisen, S., Favre, L. Probiotics, secretory IgA and inflammation. US20110268743 (2011).
86. Smith, B., Broadbent, R. Probiotic preparation for treating gut inflammation. WO2016124940 (2016).
87. Kekkonen, R. Novel use of probiotics. WO2010130785 (2010).
88. O’Neill, C., McBain, A. Probiotic bacteria. US20150079040 (2015).
89. Lu, Y.C., Hsieh, F.C., Tsai, C.C., Huang, C.Y., Wang, H.F., Tseng, C.Y. Use of probiotic strain GM-080 in treating cardiac inflammation and apoptosis. US20120052047 (2012).
90. Huang, C.M. Skin probiotic. WO2015106175 (2015).
91. Ikegami, S., Makino, S., Toshimitsu, T., Itoh, H., Nakao, A. Composition for preventing inflammations. US20130302844 (2013).
92. Rescigno, M., Loguercio, C., Grossi, E. Therapeutic use of probiotics. US20120087902 (2012).
93. Nielsen, B., Nielson, E. Packaged probiotic composition and uses thereof. US20160199531 (2016).
94. Raspaud, S.L., Grompone, G., Capronnier, S., Chambaud, I., Smokvina, T., Degivry, M., Lesic, B., Neunlist, M. Probiotic strains for use in improving the enteric nervous system. WO2011148355 (2011).
95. Haag, K.J.H., Fichot, M.C., Rochat, F., Sprenger, N. Probiotics to reduce development of allergy in infants born by caesarean section. CA2678994 (2008).
96. Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005; 192: 394-8.
97. Humen MA, De Antoni GL, Benyacoub J, Costas ME, Cardozo MI, Kozubsky L, et al. Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun 2005; 73: 1265-9.
98. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005; 191: 25-32.
99. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: Recent advances. Inflam Bowel Dis 2009; 15(2): 300-10.
100. Ohashi Y, Ushida K. Health-beneficial effects of probiotics: Its mode of action. Anim Sci J 2009; 80(4): 361-71.
101. Vila B, Esteve-Garcia E, Brufau J. Probiotic micro-organisms: 100 years of innovation and efficacy; Modes of action. World Poult Sci J 2010; 66(3): 369-80.
102. Hemaiswarya S, Raja R, Ravikumar R, Carvalho IS. Mechanism of action of probiotics. Braz Arch Biol Technol 2013; 56(1): 113-19.
103. Ashraf R, Shah NP. Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr 2014; 54(7): 938-56.
104. Kang HJ, Im SH. Probiotics as an immune modulator. J Nutr Sci Vitaminol 2015; 61 (Suppl): S103-05.
105. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis 2008; 46 (Suppl 2): S87-91. S144-51.
106. Kim CJ, Walmsley SL, Raboud JM, Kovacs C, Coburn B, Rousseau R, et al. Can probiotics reduce inflammation and enhance gut immune health in people living with HIV: Study designs for the probiotic visbiome for inflammation and translocation (Proov it) pilot trials. HIV Clin Trials 2016; 17(4): 147-57.
107. Chenoll E, Casinos B, Bataller E, Astals P, Echevarría J, Iglesias JR, et al. A novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacteria Helicobacter pylori. Appl Environ Microbiol 2011; 77: 1335-43.
108. Cursino L, Smajs D, Smarda J, Nardi RM, Nicoli JR, Chartone-Souza E, et al. Exoproducts of the Escherichia coli strain H22 inhibiting some enteric pathogens both in vitro and in vivo. J Appl Microbiol 2006; 100: 821-29.
109. Stern NJ, Eruslanov BV, Pokhilenko VD, Kovalev YN, Volodina LL, Perelygin VV. Bacteriocins reduce Campylobacter jejuni colonization while bacteria producing bacteriocins are ineffective. Microb Ecol Health Dis 2008; 20: 74-9.
110. Messaoudi S, Manai M, Kergourlay G, Prévost H, Connil N, Chobert JM, et al. Lactobacillus salivarius: Bacteriocin and probiotic activity. Food Microbiol 2013; 36(2): 296-304.
111. Winkler P, Ghadimi D, Schrezenmeir J, Kraehenbuhl JP. Molecular and cellular basis of microflora host interactions. J Nutr 2007; 137(3 Suppl 2): 756S-72S.
112. Taylor AL, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. Effects of probiotic supplementation for the first 6 months of life on allergen-and vaccine-specific immune responses. Clin Exp Allergy 2006; 36: 1227-35.
113. Lin JS, Chiu YH, Lin NT, Chu CH, Huang K, Liao KW, et al. Different effects of probiotic species/ strains on infections in preschool children: A double-blind, randomized, controlled study. Vaccine 2009; 27:1073-9.
114. Foligné B, Daniel C, Pot B. Probiotics from research to market: The possibilities, risks and challenges. Curr Opin Microbiol 2013; 16(3): 284-92.
115. Schwartz JS, Peres AG, Mfuna Endam L, Cousineau B, Madrenas J, Desrosiers M. Topical probiotics as a therapeutic alternative for chronic rhinosinusitis: A preclinical proof of concept. Am J Rhinol Allergy 2016; 30(6): e202-05.
116. Özdemir Ö. Mechanisms of preventative and therapeutic role of probiotics in different allergic and autoimmune disorders. Open J Immun 2013; 3(3): 103-18.
117. Jeurink PV, Rijnierse A, Martin R, Garssen J, Knippels LMJ. Difficulties in describing allergic disease modulation by pre-, pro-and synbiotics. Curr Pharm Design 2012; 18(16): 2369-74.
118. Castellazzi AM, Valsecchi C, Caimmi S, Licari A, Marseglia A, Leoni MC, et al. Probiotics and food allergy. Ital J Pediatr 2013; 39: 47.
119. Maassen C, van Holten-Neelen C, Balk F, den Bak-Glashouwer MJ, Leer RJ, Laman JD, et al. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000; 18: 2613-23.
120. Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF, et al. Identification of strong interleukin-10 inducing lactic acid bacteria which downregulate T helper type 2 cytokines. Clin Exp Allergy 2005; 35: 1481-9.
121. Neaua E, Delannoy J, Marion C, Cottart CH, Labellie C, Holowacz S. Three novel candidate probiotic strains with prophylactic properties in a murine model of cow's milk allergy. Appl Environ Microbiol 2016; 82(6): 1722-33.
122. Prakash S, Tomaro-Duchesneau C, Saha S, Rodes L, Kahouli I, Malhotra M. Probiotics for the prevention and treatment of allergies, with an emphasis on mode of delivery and mechanism of action. Curr Pharm Design 2014; 20(6): 1025-37.
123. Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki K, Saito T. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin Exp Immunol 2006; 145: 130-8.
124. Kim JY, Choi YO, Ji GE. Effect of oral probiotics (Bifidobacterium lactis AD 011 and Lactobacillus acidophilus AD 031) administration on ovalbumin-induced food allergy mousemodel. J Microbiol Biotechnol. 2008; 18: 1393-400.
125. Patel S, Shukla R, Goyal A. Probiotics in valorization of innate immunity across various animal models. J Funct Foods 2015; 14: 549-61.
126. West CE, Rydén P, Lundin D, Engstrand L, Tulic MK, Prescott SL. Gut microbiome and innate immune response patterns in IgEassociated eczema. Clin Exp Allergy 2015; 45 (9): 1419-29.
127. Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebocontrolled trial. J Allergy Clin Immunol 2008; 122:788-94.
128. Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/ dermatitis syndrome infants. Pediatr Allergy Immunol 2005; 16: 65-71.
129. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-95.
130. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123: 335-41.
131. Lodinova-Zadnikova R, Cukrowska B, Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003; 131(3): 209-11.
132. Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, et al. Probiotics in prevention of IgEassociated eczema. A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119(5): 1174-80.
133. Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: Does it also reduce atopic sensitization? Clin Exp Allergy 2013; 43(9): 1048-57.
134. Niers LE, Hoekstra MO, Timmerman HM, van Uden NO, de Graaf PM, Smits HH, et al. Selection of probiotic bacteria for prevention of allergic diseases: Immunomodulation of neonatal dendritic cells. Clin Exp Immunol 2007; 149: 344-52.
135. Dwivedi M, Kumar P, Laddha NC, Kemp EH. Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity. Autoimmun Rev 2016; 15(4): 379-92.
136. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007; 37: 498-505.
137. Torii A, Torii S, Fujiwara S, Tanaka H, Inagaki N, Nagai H. Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 2007; 56: 293-301.
138. Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38: 611-18.
139. Lin TY, Chen CJ, Chen LK, Wen SH, Jan RH. Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: A randomized double blind controlled trial. Indian Pediatr 2013; 50(2): 209-13.
140. Di Felice G, Barletta B, Butteroni C, Corinti S, Tinghino R, Colombo P, et al. Use of probiotic bacteria for prevention and therapy of allergic diseases: Studies in mouse model of allergic sensitization. J Clin Gastroenterol 2008; 42 (Suppl 3): S130-2.
141. Giovannini M, Agostoni C, Riva E, Salvini F, Ruscitto A, Zuccotti GV, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/ or rhinitis. Pediatr Res 2007; 62: 215-20.
142. Kawase M, He F, Kubota A, Hiramatsu M, Saito H, Ishii T, et al. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double blind placebo-controlled clinical study. Int J Food Microbiol 2009; 128: 429-34.
143. Soh SE, Aw M, Gerez I, Chong YS, Rauff M, Ng YP, et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39: 571-8.
144. Blümer N, Sel S, Virna S, Patrascan CC, Zimmermann S, Herz U, et al. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy 2007; 37: 348-57.
145. Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 2007; 175: 561-9.
146. Stockert K, Schneider B, Porenta G, Rath R, Nissel H, Eichler I. Laser acupuncture and probiotics in school age children with asthma: A randomized, placebo-controlled pilot study of therapy guided by principles of traditional Chinese medicine. Pediatr Allergy Immunol 2007; 18: 160-6.
147. Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, Thalhamer J, et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003; 22(1): 87-95.
148. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002; 110(4): 617-23.
149. Hougee S, Vriesema AJ, Wijering SC, Knippels LM, Folkerts G, Nijkamp FP, et al. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: A bacterial strain comparative study. Int Arch Allergy Immunol 2010; 151(2): 107-17.
150. Rupa P, Schmied J, Wilkie BN. Prophylaxis of experimentally induced ovomucoid allergy in neonatal pigs using Lactococcus lactis. Vet Immunol Immunopathol 2011; 140(1-2): 23-9.
151. Ye_ilova Y, Çalka Ö, Akdeniz N, Berkta_ M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 2012; 24(2): 189-93.
152. Kim HJ, Kim YJ, Lee SH, Yu J, Jeong SK, Hong SJ. Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs Clin Immunol 2014; 153(1): 178-86.
153. Toomer OT, Ferguson M, Pereira M, Do A, Bigley E, Gaines D, et al. Maternal and postnatal dietary probiotic supplementation enhances splenic regulatory T helper cell population and reduces ovalbumin allergen-induced hypersensitivity responses in mice. Immunobiology 2014; 219(5): 367-76.
154. Toomer OT, Ferguson M, Pereira M, Do A, Bigley E, Gaines D, et al. Maternal and postnatal dietary probiotic supplementation enhances splenic regulatory T helper cell population and reduces peanut allergen-induced hypersensitivity responses in mice. Immunobiology. 2014; 219(9): 661-70.
155. Pessi T, Isolauri E, Sutas Y, Kankaanranta H, Moilanen E, Hurme M. Suppression of T cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. Immunopharmacol 2001; 1:211-8.
156. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168: 171-8.
157. Ruemmele FM, Bier D, Marteau P, Rechkemmer G, Bourdet-Sicard R, Walker WA, et al. Clinical evidence for immunomodulatory effects of probiotic bacteria. J Pediatr Gastroenterol Nutr 2009; 48: 126-41.
158. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic review of published randomized, double-blind, placebocontrolled trials JPGN 2001; 33: S17-S25.
159. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005; 102(8): 2880-5.
160. Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, van Deventer S. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr 2004; 80: 1618-25.
161. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 1260-7.
162. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor-2 pathway. J Allergy Clin Immunol 2006; 117: 696-702.
163. Dumot JA, Conwell DL, Zuccaro, G, Jr., Vargo JJ, Shay SS, Easley KA, Ponsky JL. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 2001; 96(7): 2098-102.
164. Martin R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermudez-Humaran LG. Role of commensal and probiotic bacteria in human health: A focus on inflammatory bowel disease. Microb Cell Surface 2013; 1271.
165. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J 2000; 14: 1749-53
166. Miquel S, Martin R, Rossi O, Bermudez-Humaran L, Chatel J, Sokol H, Thomas M, et al. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 2013; 16(3): 255-61.
167. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterol 1995; 108(1): 108-16.
168. Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, Remaut E, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterol 2004; 127(2): 502-13.
169. Seguí J, Gil F, Gironella M, Alvarez M, Gimeno M, Coronel P, et al. Down-regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis. Inflam Bowel Dis 2005; 11(10): 872-82
170. Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2007; 293(4): G729-38.
171. Bermúdez-Humarán LG, Motta JP, Aubry C, Kharrat P, Martin LR, Sallenave JM, et al. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci. Microb Cell Fact 2015; 14: 26.
172. Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema. Curr Opin Allergy Clin Immunol 2013; 13: 280-86.
173. Foolad N, Brezinski EA, Chase EP, Armstrong AW. Effect of nutrient supplementation on atopic dermatitis in children: A systematic review of probiotics, prebiotics, formula, and fatty acids. JAMA Dermatol 2013; 149: 350-55.
174. Pessi T, Sutas Y, Hurme H, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000; 30: 1804-08.
175. Blümer N, Sel S, Virna S, Patrascan CC, Zimmermann S, Herz U, et al. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy 2007; 37(3): 348-57.
176. Kruisselbrink A, Den H, Bak-Glashouwer MJ, Havenith CE, Thole JE, Janssen R. Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses. Clin Exp Immunol 2001; 126(1): 2-8.
177. Khan MW, Zadeh M, Bere P, Gounaris E, Owen J, Klaenhammer T, et al. Modulating intestinal immune responses by lipoteichoic acid-deficient Lajctobacillus acidophilus. Immunother 2012; 4(2):151-61.
178. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci USA 2011; 108: 4623-30.
179. Hamilton-Mille HMT. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Intl J Antimicrob Agents 2008; 22(4): 360-66.
180. Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review. Clin Therapeutics 2008; 30(3): 453-68.
181. Hao Q, Dong BR, Wu T. Probiotics in preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2015; 2: 1-72. CD006895.
182. Stapleton AE, An-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled Phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011; 52(10): 1212-17.
183. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001; 30: 49-52.
184. Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: Diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol 2016; 111: 602-22.
185. Sgouras D, Maragkoudakis P, Petraki K, MartinezGonzalez B, Eriotou E, Michopoulos S, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004; 70: 518-26.
186. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo controlled trial. Gastroenterol 2000; 119: 305-9.
187. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, doubleblind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001; 13: 1143-47.
188. Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME. Probiotics for the prevention of respiratory tract infections: A systematic review. Intl J Antimicrob Agents 2009; 34(3): 197.e1-197.e10.
189. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: A randomized, double-blind, placebo-controlled trial. Clin Nutr 2010; 29(3): 312-16.